Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial.
Saved in:
| Title: | Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial. |
|---|---|
| Authors: | Litwin AH; School of Health Research, Clemson University, Clemson, SC, USA; Department of Medicine, University of South Carolina School of Medicine, Greenville, SC, USA; Department of Medicine, Prisma Health, Greenville, SC, USA. Electronic address: alain.litwin@prismahealth.org., Lum PJ; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Taylor LE; College of Pharmacy, University of Rhode Island, Providence, RI, USA; HIV and Viral Hepatitis Services, CODAC Behavioral Health, Providence, RI, USA., Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Tsui JI; Department of Medicine, University of Washington, Seattle, WA, USA., Feinberg J; Department of Behavioral Medicine and Psychiatry, and Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, Morgantown, WV, USA., Kim AY; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Norton BL; Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA., Heo M; Department of Public Health Sciences, Clemson University, Clemson, SC, USA., Arnsten J; Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA., Meissner P; Department of Family and Social Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA., Karasz A; Department of Family Medicine & Community Health, University of Massachusetts Chan Medical School, Worcester, MA, USA., Mckee MD; Department of Family Medicine & Community Health, University of Massachusetts Chan Medical School, Worcester, MA, USA., Ward JW; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Decatur, GA, USA., Johnson N; New York City Department of Health and Mental Hygiene, New York City, NY, USA., Pericot-Valverde I; Department of Psychology, Clemson University, Clemson, SC, USA; School of Health Research, Clemson University, Clemson, SC, USA., Agyemang L; Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA., Stein ES; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Thomas A; College of Pharmacy, University of Rhode Island, Providence, RI, USA., Borsuk C; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Blalock KL; Department of Medicine, University of Washington, Seattle, WA, USA., Wilkinson S; Office of Research Program Management, West Virginia University School of Medicine, Morgantown, WV, USA., Wagner K; University of New Mexico Health Sciences Center, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA., Roche J; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Murray-Krezan C; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Anderson J; University of New Mexico Health Sciences Center, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA., Jacobsohn V; Department of Psychiatry and Behavioral Sciences, University of New Mexico, Albuquerque, NM, USA., Luetkemeyer AF; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Falade-Nwulia O; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Page K; University of New Mexico Health Sciences Center, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA. |
| Corporate Authors: | HERO Study Group |
| Source: | The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2022 Dec; Vol. 7 (12), pp. 1112-1127. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't; Pragmatic Clinical Trial |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
